Podcast: Download (Duration: 1:01 — 1.4MB)
Subscribe: RSS
Psilocybin compared favorably with a traditional antidepressant for treating moderate to severe depression, a recent study found. Matthew Johnson, a psychedelics researcher at Johns Hopkins, says an entirely different clinical approach will be required to use psilocybin routinely for depression. …
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
For people with depression, sometimes traditional antidepressant medicines simply don’t work. Now psychedelic medicines may be a new choice, if the results of a study comparing psilocybin to escitalopram, an antidepressant, hold up. Matthew Johnson, a psychedelics researcher at Johns …
Could psychedelic medicines replace antidepressants? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Depression can be hard to treat, with even established medicines taking time to be effective and perhaps not helping at all. Now a new study compared the psychedelic drug psilocybin with escitalopram, an established antidepressant, and the results impressed Matthew …
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Can the psychedelic drug psilocybin be used to treat depression? That possibility was examined in a recent study comparing psilocybin to escitalopram, an established antidepressant, in people with moderate to severe depression. Matthew Johnson, a psychedelics researcher at Johns Hopkins, …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Children don’t get severe Covid-19 disease as often as older people do. That assertion underpins decisions to travel with children and otherwise exercise fewer precautions against infection in this population. Yet Covid is not benign for kids. That’s according to …
How has Covid-19 impacted on kids so far? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
As the Covid pandemic rages on, more younger people are becoming infected, and more variants are being reported. Aaron Milstone, a pediatric infectious disease expert at Johns Hopkins, is concerned that children might begin experiencing infections more commonly as a …
How problematic are Covid variants for children? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
Multisystem inflammatory syndrome in children, abbreviated MIS-C, appears to be on the rise in the US. Aaron Milstone, a pediatric infectious disease expert at Johns Hopkins, says the syndrome may sneak up in unpredictable ways. Milstone: We have a lot …
What happens when a child develops MIS-C? Elizabeth Tracey reports Read more »
